Inhaled Treprostinil after Initial Clinical Worsening: To Continue or Not to Continue, That's the Question.
作者信息
Jin Qi, Guan Lihua, Pan Wenzhi, Zhang Xiaochun, Chen Dandan, Zhou Daxin
机构信息
Zhongshan Hospital, Fudan University Shanghai, China.
出版信息
Am J Respir Crit Care Med. 2022 May 15;205(10):1250-1251. doi: 10.1164/rccm.202112-2721LE.
Abstract
摘要
相似文献
1
Inhaled Treprostinil after Initial Clinical Worsening: To Continue or Not to Continue, That's the Question.初始临床病情恶化后吸入用曲前列尼尔：继续还是停止，这是个问题。
Am J Respir Crit Care Med. 2022 May 15;205(10):1250-1251. doi: 10.1164/rccm.202112-2721LE.
2
Reply to Jin .: Inhaled Treprostinil after Initial Clinical Worsening: To Continue or Not to Continue, That's the Question.对金的回复：初始临床病情恶化后吸入曲前列尼尔：继续还是停止，这是个问题。
Am J Respir Crit Care Med. 2022 May 15;205(10):1251-1252. doi: 10.1164/rccm.202201-0081LE.
3
Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial.INCREASE 试验中吸入曲前列尼尔治疗特发性肺纤维化相关性肺动脉高压患者多疾病进展事件的疗效。
Am J Respir Crit Care Med. 2022 Jan 15;205(2):198-207. doi: 10.1164/rccm.202107-1766OC.
4
The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.吸入性曲前列尼尔治疗肺动脉高压的潜力。
Ther Adv Respir Dis. 2011 Jun;5(3):195-206. doi: 10.1177/1753465810397693. Epub 2011 Feb 7.
5
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.特发性肺纤维化相关肺动脉高压患者应用吸入曲前列尼尔治疗
N Engl J Med. 2021 Jan 28;384(4):325-334. doi: 10.1056/NEJMoa2008470. Epub 2021 Jan 13.
6
[Prostaglandin 12 analogs (epoprostenol and treprostinil) as a treatment for refractory bronchopulmonary dysplasia-induced pulmonary hypertension in an infant].[前列环素12类似物（依前列醇和曲前列尼尔）治疗婴儿难治性支气管肺发育不良所致肺动脉高压]
Arch Argent Pediatr. 2019 Aug 1;117(4):e413-e415. doi: 10.5546/aap.2019.e413.
7
Use of inhaled treprostinil in patients with interstitial lung disease and pulmonary hypertension: to boldly go where no other pulmonary vasodilator has gone before?吸入性曲前列尼尔在间质性肺疾病合并肺动脉高压患者中的应用：大胆探索其他肺血管扩张剂未曾涉足之地？
Thorax. 2024 Mar 15;79(4):295-296. doi: 10.1136/thorax-2023-221167.
8
Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension.吸入用前列环素钠治疗肺动脉高压。
Expert Opin Pharmacother. 2011 Nov;12(16):2583-93. doi: 10.1517/14656566.2011.622269.
9
Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension.肺动脉高压患者吸入曲前列尼尔的长期疗效：曲前列尼尔钠吸入治疗肺动脉高压（TRIUMPH）研究开放性扩展。
J Heart Lung Transplant. 2011 Dec;30(12):1327-33. doi: 10.1016/j.healun.2011.08.019.
10
Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.西地那非与吸入性曲前列尼尔联合应用对肺动脉高压血流动力学和气体交换的急性影响
Pulm Pharmacol Ther. 2008 Oct;21(5):824-32. doi: 10.1016/j.pupt.2008.07.003. Epub 2008 Jul 9.
引用本文的文献
1
Xenon-129 magnetic resonance imaging and spectroscopy detects response to therapy in pulmonary hypertension.氙-129磁共振成像与波谱分析可检测肺动脉高压的治疗反应。
Eur Respir J. 2025 Feb 27;65(2). doi: 10.1183/13993003.01651-2024. Print 2025 Feb.
本文引用的文献
1
Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial.INCREASE 试验中吸入曲前列尼尔治疗特发性肺纤维化相关性肺动脉高压患者多疾病进展事件的疗效。
Am J Respir Crit Care Med. 2022 Jan 15;205(2):198-207. doi: 10.1164/rccm.202107-1766OC.
2
Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study.吸入性曲前列尼尔与用力肺活量在间质性肺疾病合并肺动脉高压患者中的相关性：INCREASE 研究的事后分析。
Lancet Respir Med. 2021 Nov;9(11):1266-1274. doi: 10.1016/S2213-2600(21)00165-X. Epub 2021 Jun 29.
3
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.特发性肺纤维化相关肺动脉高压患者应用吸入曲前列尼尔治疗
N Engl J Med. 2021 Jan 28;384(4):325-334. doi: 10.1056/NEJMoa2008470. Epub 2021 Jan 13.
4
Impact of inhaled treprostinil on risk stratification with noninvasive parameters: a post hoc analysis of the TRIUMPH and BEAT studies.吸入性曲前列尼尔对无创参数风险分层的影响：TRIUMPH和BEAT研究的事后分析
Pulm Circ. 2020 Dec 14;10(4):2045894020977025. doi: 10.1177/2045894020977025. eCollection 2020 Oct-Dec.
5
Pulmonary veno-occlusive disease is highly prevalent in scleroderma patients undergoing lung transplantation.肺静脉闭塞性疾病在接受肺移植的硬皮病患者中非常普遍。
ERJ Open Res. 2019 Feb 11;5(1). doi: 10.1183/23120541.00168-2018. eCollection 2019 Feb.
6
Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension.硬皮病患者出现毛细血管前性肺动脉高压时肺静脉闭塞病的计算机断层扫描结果
Arthritis Rheum. 2012 Sep;64(9):2995-3005. doi: 10.1002/art.34501.
Zotero 插件